yourstate.us
21 CFR 876.4310

§ 876.4310 Endoscopic electrosurgical clip cutting system.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 876.4310, § 876.4310 Endoscopic electrosurgical clip cutting system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/90299
Permanent ID
ys:prov:90299@1
SHA-256
bf4bca1e26634ab674f2c00a0dfdc9ed7ac87edd8cfefa3581dfa18d5c6e12d8

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. An endoscopic electrosurgical clip cutting system is a prescription device that applies electrical energy to fragment metallic clips, which are devices placed in the digestive tract to close gastrointestinal perforations, hemorrhages, or perform resection. The system includes instruments that are then used to remove the fragmented clips from the digestive tract. (b) Classification. Class II (special controls). The special controls for this device are: (1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested: (i) Performance bench testing to evaluate the functionality (including stress, compatibility, usability, and reliability) of the device during use; (ii) Electrical and thermal safety testing; and (iii) Electromagnetic compatibility testing. (2) Animal testing must evaluate tissue damage, including thermal effects, during the clip removal procedure. This testing must also evaluate usability and effectiveness of the device. (3) The patient-contacting components of the device must be demonstrated to be biocompatible. (4) Performance data must demonstrate the sterility of the device components intended to be provided sterile. (5) Performance data must support shelf life by demonstrating continued sterility of the device (or the sterile components), package integrity, and device functionality over the labeled shelf life. (6) Labeling of the device must include: (i) Instructions for use, and (ii) A shelf life for single use components.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.